On May 20, 2022 SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, reported that Marco Taglietti, President and Chief Executive Officer of SCYNEXIS, will present in person at the upcoming H.C. Wainwright Global Investment Conference, being held May 23-26, 2022, in Miami and virtually (Press release, Scynexis, MAY 20, 2022, https://ir.scynexis.com/news/detail/291/scynexis-to-present-at-upcoming-h-c-wainwright-global-investment-conference [SID1234614919]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
SCYNEXIS Presentation details:
H.C. Wainwright Global Investment Conference
Location: Fontainebleau Miami Beach Hotel, 4441 Collins Avenue, Miami Beach, Fla.
Format: In person presentation and 1-on-1 meetings
Date: Wednesday, May 25, 2022
Time: 11 a.m. – 11:30 a.m. EDT